Nasser Institute Hospital
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Nasser Institute Hospital
Apr 16, 2024, 11:48 |
Blog
Rasha Aboelhassan: Thanks for the ESTRO organizing group for this very fruitful workshop, and webinars, that explained the whole issues and challenges of re-irradiation
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn: "Have…
Apr 2, 2024, 03:39 |
Blog
Rasha Aboelhassan: Cancer patients are the best heroes
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn: "When…
Mar 16, 2024, 20:38 |
Opinion
Rasha Aboelhassan: Great idea of research comes from the greatest unmet needs
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a LinkedIn post by The Nobel…
Feb 6, 2024, 16:35 |
Blog
Rasha Aboelhassan: Let's take a moment to reflect on the unsung heroes of the field
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn: "Every year on February 4th,…
Nov 26, 2023, 18:09 |
Insight
Rasha Aboelhassan: The best research is that when you investigate why some people do not get their best service...
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn: "Sometimes, you think that…
All:
5
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube